Kodiak Sciences Inc.
KOD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.16 | -0.02 | 0.00 |
| FCF Yield | -3.81% | -17.68% | -19.80% | -5.76% |
| EV / EBITDA | -13.72 | -3.31 | -1.47 | -11.39 |
| Quality | ||||
| ROIC | 0.00% | -22.36% | -21.25% | -14.40% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 50.00% |
| Cash Conversion Ratio | 0.54 | 0.64 | 0.51 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 5.36% | -18.60% | 2.81% | -41.35% |
| Safety | ||||
| Net Debt / EBITDA | 0.16 | 0.82 | 1.36 | 2.61 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -69.61 | -87.53 | -26.44 |